Your session is about to expire
← Back to Search
SMS Text Messaging for Substance Use Disorders (TEXT2 Trial)
N/A
Recruiting
Led By Marina Tolou-Shams, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 13-18
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days post baseline
Awards & highlights
TEXT2 Trial Summary
This trial will test whether sending text messages can help young people with substance abuse or mental health issues stay on track with their treatment.
Who is the study for?
This trial is for English-speaking youths aged 13-18 who are involved with the justice system and living in the community. They must have a mobile phone or tablet, be willing to send and receive texts, and be referred to substance use or mental health treatment along with having an adult caregiver.Check my eligibility
What is being tested?
The study tests if tailored SMS text messages can help improve attendance and engagement in treatment programs for youth dealing with substance use or dual diagnosis compared to standard care practices.See study design
What are the potential side effects?
Since this trial involves communication through text messaging rather than medication, there are no direct medical side effects. However, participants may experience increased stress or anxiety from receiving regular communications about their treatment.
TEXT2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 13 and 18 years old.
TEXT2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 180 days post baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days post baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Treatment session attendance
Secondary outcome measures
First treatment session initiation
Other outcome measures
Alcohol use
Characteristics of Communication and Interaction with Probation Officers and Treatment Providers
Drug Use
+5 moreTEXT2 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SMS Text MessagingExperimental Treatment1 Intervention
SMS text messaging intervention for a period of 90 days to encourage attendance at community-based substance use or dual diagnosis treatment appointments through motivational messages.
Group II: Standard of Care Engagement PracticesActive Control1 Intervention
Standard of care engagement practices, such as communicating with youth and caregivers, as needed, through texting but frequency of contact and content of messaging varies according to individual needs.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SMS Text Messaging
2018
N/A
~770
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,431 Total Patients Enrolled
68 Trials studying Substance Use
37,926 Patients Enrolled for Substance Use
University of California, San FranciscoLead Sponsor
2,500 Previous Clinical Trials
15,236,309 Total Patients Enrolled
6 Trials studying Substance Use
2,539 Patients Enrolled for Substance Use
Marina Tolou-Shams, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
420 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a mobile phone or tablet.You are currently seeking treatment for substance abuse or mental health in a community-based program.I am a young person who speaks English and have an adult willing to care for me.You are comfortable with sending and receiving text messages.I am between 13 and 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: SMS Text Messaging
- Group 2: Standard of Care Engagement Practices
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Am I eligible to contribute to this clinical experiment?
"To qualify for this clinical trial, aspiring participants must have evidence of drug use and be aged between 13 to 18. A total of 162 candidates will be taken on by the study."
Answered by AI
How many participants are engaged in this research endeavor?
"Aye, the clinicaltrials.gov records suggest that this research protocol is actively enrolling participants. This investigation was published on May 1st 2020 and saw its most recent update on August 15th 2022. 162 patients need to be recruited from a single site for the trial's completion."
Answered by AI
Can participants younger than 60 join this research endeavor?
"As mandated by the inclusion criteria, eligible participants must be between 13 and 18 years of age."
Answered by AI
Are new entrants still being accepted into the experimental trial?
"Affirmative. The information hosted on clinicaltrials.gov states that this medical study, first posted on May 1st 2020, is actively searching for participants. 162 individuals need to be recruited from a single location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger